OraSure Technologies | OSUR - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Agilent USD 476M 48M 2025-12
AngioDynamics USD 36.57M 3.79M 2025-09
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Bio Techne USD 113.69M 2.52M 2025-12
Bio-Rad Laboratories USD 221M 14.2M 2025-12
Bruker USD 247.2M 4.7M 2025-12
Cerus USD 19.33M 1.55M 2024-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Danaher USD 1.86B 166M 2026-03
Dentsply International USD 383M 28M 2025-12
Dexcom USD 349.7M 49.8M 2026-03
Illumina USD 272M 11M 2026-03
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 613.3M 73.8M 2026-03
IQVIA Holdings USD 468M 46M 2025-12
Mesa Laboratories USD 27.31M 380K 2024-09
Mettler Toledo International USD 259.83M 11.43M 2025-12
Myriad Genetics USD 122.3M 6.7M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Quidel USD 194.4M 7.5M 2025-12
Repligen USD 74.36M 703K 2025-12
Revvity USD 251.73M 9.82M 2025-12
STAAR Surgical USD 38.94M 20.44M 2025-12
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Trinity Biotech USD 6.19M 2.18M 2025-09
Waters USD 394M 153.99M 2026-03